Dew­point Ther­a­peu­tics re­struc­tures to ‘make room’ for en­try in­to the clin­ic next year in on­col­o­gy, ALS

Con­den­sate mod­u­la­tor start­up Dew­point Ther­a­peu­tics is go­ing through a re­struc­tur­ing as it gears up for its first clin­i­cal tri­als next year in col­orec­tal can­cer and …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER